Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/34930
Title: | Drug survival analysis of tofacitinib in patients with rheumatoid arthritis |
Authors: | Uludağ Üniversitesi/Sağlık Bilimleri Enstitüsü/Biyoistatistik Anabilim Dalı. Uludağ Üniversitesi/Tıp Fakültesi/Romatoloji Anabilim Dalı. Karakoç, Yenal Ercan, İlker ABF-2367-2020 |
Keywords: | Rheumatology |
Issue Date: | Jun-2018 |
Publisher: | BMJ Publishing Group |
Citation: | Karakoç, Y. ve Ercan, İ. (2018). ''Drug survival analysis of tofacitinib in patients with rheumatoid arthritis''. Annals of the Rheumatic Diseases, 77(Supplement 2), 1411-1411. |
Description: | Bu çalışma, 13-16, Haziran 2018 tarihlerinde Amsterdam[Hollanda]’da düzenlenen Congress of the European-League-Against-Rheumatism (EULAR) Kongresi‘nde bildiri olarak sunulmuştur. |
URI: | https://doi.org/10.1136/annrheumdis-2018-eular.1893 https://ard.bmj.com/content/77/Suppl_2/1411.1 http://hdl.handle.net/11452/34930 |
ISSN: | 0003-4967 1468-2060 |
Appears in Collections: | Web of Science |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Karakoç_ve_Ercan_2018.pdf | 181.33 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License